. Self-targeting spacers of S. schleiferi and S. haemolyticus. The two S. schleiferi strains of interest contain self-targets that occur within a predicted prophage, with strain 5909-02 containing three self-targeting spacers and strain 2317-03 containing two. Both strains of S. haemolyticus selected for further study contain the same exact self-targeting spacer. The sequences downstream of the target are colored based on their similarity to the SauCas9 NNGRR(T) PAM where bases in red match the PAM motif and blue bases do not. the presence of increasing amounts of BSA or AcrVA4 using the same range of concentrations as the Acrs in A. Reactions were performed by adding Acrs after complexing Cas9 and sgRNA. Uncleaved and cleaved dsDNA products are indicated by green and blue arrows, respectively. (C) Agarose gels showing cleavage of dsDNA target by Cas9 in the presence of increasing amounts of BSA or AcrVA4 (left to right: 1000 nM, 2000 nM, 4000 nM). Reactions were performed by adding Acrs before complexing Cas9 and sgRNA. Uncleaved and cleaved dsDNA products are indicated by green and blue arrows, respectively. Figure S6. Mammalian validation system to assess Acr proteins. Assessment of genome editing inhibition efficiency by various anti-CRISPR (Acr) protein candidates or controls. HEK-RT1 genome editing reporter cells, expressing a doxycycline-inducible GFP marker, were sequentially transduced with lentiviral vectors expressing mTagBFP2 (pCF525-mTagBFP2, HygroR), SauCas9 (pCF825, PuroR), and SauCas9 sgRNAs (pCF824-sgC/sgGFP, mCherry). At day three post sgRNA transduction, the HEK-RT1 reporter cells were treated with doxycycline for 24 h, followed by flow cytometry-based quantification of GFP fluorescence. For sgRNA expressing samples, quantification was gated on the mCherry-positive population. sgC: negative control sgRNA. sgGFP: GFP-targeting sgRNA. R6: GFP-positive, live single cells. R4: GFP-positive, mCherry-positive, live single cells. GFP-H: GFP fluorescence intensity, signal height. FSC-A: forward scatter, signal area. Figure S7 . Quantification of AcrIIA4, AcrIIA5, and AcrIIA6 inhibition of SauCas9. Testing of three known Acrs for their ability to inhibit the genome editing activity of SauCas9 and SpyCas9 in human cells. HEK-RT1 genome editing reporter cells were sequentially transduced with lentiviral vectors expressing AcrIIA4, AcrIIA5, AcrIIA6, or mTagBFP2 (pCF525-AcrIIA, HygroR), SauCas9 (pCF825, PuroR) or SpyCas9 (pCF823, PuroR), and SauCas9 sgRNAs (pCF824-sgC/sgGFP, mCherry) or SpyCas9 sgRNAs (pCF820-sgC/sgGFP, mCherry). At day three post sgRNA transduction, the reporter cells were treated with doxycycline for 24 h, followed by flow cytometry-based quantification of GFP fluorescence. Error bars represent the standard deviation of triplicates. sgC: negative control guide RNAs for respective Cas9. sgGFP1/sgGFP8: GFP-targeting guide RNAs for the respective Cas9. The data shown for mTagBFP2 is partially quantification of data shown in Fig. S6 . Figure S8 . AcrIIA13 potently and selectively inhibits SauCas9. Assessment of SauCas9 and SpyCas9 genome editing inhibition efficiency by AcrIIA13 in human cells. HEK-RT1 genome editing reporter cells were sequentially transduced with lentiviral vectors expressing AcrIIA13 (pCF525-AcrIIA, HygroR), SauCas9 (pCF825, PuroR) or SpyCas9 (pCF823, PuroR), and SauCas9 sgRNAs (pCF824-sgC/sgGFP, mCherry) or SpyCas9 sgRNAs (pCF820-sgC/sgGFP, mCherry). At day three post sgRNA transduction, the reporter cells were treated with doxycycline for 24 h, followed by flow cytometry-based quantification of GFP fluorescence. sgC: negative control sgRNAs for respective Cas9. sgGFP: GFPtargeting sgRNAs for the respective Cas9. R6: GFP-positive, live single cells. R4: GFP-positive, mCherry-positive, live single cells. GFP-H: GFP fluorescence intensity, signal height. FSC-A: forward scatter, signal area. Table S1 . Filtered List of Staphylococcus II-A self-targeting instances within one indel/mutation of the NNGRR(T) PAM. The list of genomes containing type II-A self-targeting instances was filtered by comparing the bases downstream of the aligned target sequence to the known SauCas9 PAM sequence, NNGRR(T). Self-targeting instances were kept if the sequences downstream of the target matched within one indel or mutation of SauCas9 PAM sequence (final T optional), given these sequences would be most likely to yield a lethal self-target and thus be more likely to contain an Acr gene. The PAM filtered list resulted in 12 genomes containing type II-A CRISPR self-targeting. To narrow the search further, the list was sorted based on the similarity of each system's Cas9 to SauCas9 (CCK74173.1 from S. aureus subsp. aureus M06/0171). We also used PHASTER (28) and Islander (29) to determine if any of the self-targets occur within prophages. Self-targets found in prophages with no target sequence mutations and a bona fide PAM sequence are hallmarks of the scenario described in Fig. 1A , where protospacers are acquired from an Acr-carrying phage before the phage integrates to create the self-targeting spacer.
Identity to SauCas9
Cas9 Table S2 . Genomic amplicons tested for Acr activity. The predicted MGEs found in S. schleiferi strain 5909-02 and S. haemolyticus strain W75 were broken up into 27 ~10 kb genomic fragment (GF) amplicons in total to screen for Acr activity. We were unable to amplify one of the S. haemolyticus fragments, thus it was not screened. The three self-targets in S. schleiferi strain 5909-02 can be found distributed across three genomic fragment amplicons. The self-target for S. haemolyticus is not captured by the amplicons because it falls in a contig that is too short for reliable MGE prediction, and does not contain any complete genes. The Cas9 amplicons used for GF screening ( Fig. 2A) are also indicated. Table S3 . Acr candidates identified using guilt-by-association approach. A summary of the 10 different candidates tested for Acr activity in TXTL identified from the guilt-by-association approach using GF5 gene 1 (Fig. S2B, S3, Fig. 2E ). Candidate proteins 1 and 10 were found to inhibit SauCas9. Proteins marked with an asterisk were not predicted correctly on the NCBI database and therefore do not have an accession number, or the accession number contains a shortened form of the protein. The proteins found in GF5 used to seed the guilt-by-association search are also listed. Candidate 1 was tested in TXTL using a methionine start codon, replacing the wildtype leucine. AcrIIA13a under pTet pKEW277
Contig

Self
GF5 cand1 under pTet pKEW345
Candidate 1 under pTet (AcrIIA14) pKEW346
Candidate 2 under pTet pKEW347
Candidate 3 under pTet pKEW348
Candidate 4 under pTet pKEW349
Candidate 5 under pTet pKEW350
Candidate 6 under pTet pKEW351
Candidate 7 under pTet pKEW352
Candidate 8 under pTet pKEW372
Candidate 9 under pTet pKEW373
Candidate 10 under pTet (AcrIIA15) pKEW332
AcrIIA13 N-terminus under pTet pKEW331
AcrIIA13 C-terminus under pTet 
